妊娠及产后溶血性尿毒症综合征的补体基因变异与预后
随访7.2年,53%进展至终末期肾病,28%复发,肾移植后54%复发。结论认为其严重程度与补体变异频率与非妊娠相关非典型溶血性尿毒症综合征相同。
要点
- 妊娠相关溶血性尿毒症综合征多发生于产后(76%),56%检出补体基因变异。
- 随访7.2年,53%进展至终末期肾病,28%复发,肾移植后54%复发。
- 其严重程度与补体变异频率与非妊娠相关非典型溶血性尿毒症综合征相同。
核心结论
- 妊娠相关溶血性尿毒症综合征与非妊娠相关非典型溶血性尿毒症综合征在起病及随访期严重程度相同,补体基因变异频率也相同。
主要发现
- 溶血性尿毒症综合征主要发生于首次妊娠(58%)和产后(76%)。
- 诊断时56例(71%)需透析;56例(78%)接受血浆置换,21例(41%)接受血浆输注,4例(5%)接受依库珠单抗。
- 随访平均7.2年,41例(53%)达终末期肾病,15例(19%)患慢性肾脏病,18例(28%)复发。
- 49例(56%)检出补体基因变异,主要位于CFH(30%)和CFI(9%)。
临床怎么用
- 妊娠相关溶血性尿毒症综合征患者应评估补体基因变异,因其频率与非妊娠相关非典型溶血性尿毒症综合征相同。
- 肾移植前需告知复发风险(54%),并考虑补体抑制治疗等管理策略。
局限性
- 回顾性研究设计。
- 原文未报告具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pregnancy is associated with various forms of thrombotic microangiopathy, including hemolytic uremic syndrome. A previous small French study suggested that pregnancy-associated hemolytic uremic syndrome was to be included in the spectrum of atypical hemolytic uremic syndrome linked to complement alternative pathway dysregulation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We sought to retrospectively analyze the presentation, outcome, and frequency of complement alternative pathway gene variants in a larger international (France, United Kingdom, Italy) cohort of patients with pregnancy-associated hemolytic uremic syndrome. RESULTS: Eighty-seven patients with pregnancy-associated hemolytic uremic syndrome were included. Hemolytic uremic syndrome occurred mainly during the first pregnancy (58%) and in the postpartum period (76%). At diagnosis, 56 (71%) patients required dialysis. Fifty-six (78%) patients underwent plasma exchanges, 21 (41%) received plasma infusions, and four (5%) received eculizumab. During follow-up (mean duration of 7.2 years), 41 (53%) patients reached ESRD, 15 (19%) had CKD, and 18 (28%) patients experienced hemolytic uremic syndrome relapse. Twenty-four patients (27%) received a kidney transplant and a recurrence of hemolytic uremic syndrome occurred in 13 (54%) patients. Variants in complement genes were detected in 49 (56%) patients, mainly in the CFH (30%) and CFI genes (9%). CONCLUSIONS: Pregnancy-associated hemolytic uremic syndrome and atypical hemolytic uremic syndrome nonrelated to pregnancy have the same severity at onset and during follow-up and the same frequency of complement gene variants.
引用
- Bruel A, Kavanagh D, Noris M, et al. Hemolytic Uremic Syndrome in Pregnancy and Postpartum. Clin J Am Soc Nephrol. 2017. PMID: 28596415. doi:10.2215/CJN.00280117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。